NCT07231640 PrOTECT AL: PrEP Optimization Through Enhanced Continuum Tracking
| NCT ID | NCT07231640 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Alabama at Birmingham |
| Condition | HIV |
| Study Type | INTERVENTIONAL |
| Enrollment | 56 participants |
| Start Date | 2026-02-09 |
| Primary Completion | 2030-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 56 participants in total. It began in 2026-02-09 with a primary completion date of 2030-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to enhance and evaluate the implementation of a PrEP Care Continuum data dashboard across seven distinct clinical sites in Alabama. By leveraging real-time data and fostering collaborative partnerships, this project aims to accurately visualize care disparities, allocate resources strategically, identify and address care gaps in the delivery of PrEP services, and gauge its impact on HIV prevention efforts.
Eligibility Criteria
Inclusion Criteria: * currently practicing providers (either a clinician, nurse or medical assistant), OR 2) clinical administrator (e.g., someone in a leadership role within the PrEP clinic), OR 3) a data manager (i.e., someone who collects, enters and or manages data within the clinic) AND * English speaking * Age ≥ 18. Exclusion Criteria: * Not one of the seven participating sites
Contact & Investigator
Michael Mugavero, MD
PRINCIPAL INVESTIGATOR
University of Alabama at Birmingham
Frequently Asked Questions
Who can join the NCT07231640 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying HIV. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07231640 currently recruiting?
Yes, NCT07231640 is actively recruiting participants. Contact the research team at marielparman@uabmc.edu for enrollment information.
Where is the NCT07231640 trial being conducted?
This trial is being conducted at Birmingham, United States.
Who is sponsoring the NCT07231640 clinical trial?
NCT07231640 is sponsored by University of Alabama at Birmingham. The principal investigator is Michael Mugavero, MD at University of Alabama at Birmingham. The trial plans to enroll 56 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.